NCT00638690 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 5 years
- Other-event reporting threshold
- 5%
Following interim analysis of the study by the Independent Data Monitoring Committee in August 2010, the protocol was amended to provide for the unblinding of all study participants and the option for placebo participants to receive abiraterone acetate treatment; 67 placebo participants crossed over.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Abiraterone Acetate | 365 / 791 | 766 / 791 | Not reported / Not reported |
| Placebo | 175 / 394 | 381 / 394 | Not reported / Not reported |
| Placebo to Abiraterone Acetate | 29 / 67 | 57 / 67 | Not reported / Not reported |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 26
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 15
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 67
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Coagulopathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Pancytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Bradycardia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Hypoacusis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Tinnitus
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Vertigo
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Hyperglycaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Blindness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Diplopia
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 202
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 105
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 11
- num At Risk
- 67
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 236
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 124
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 67
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 166
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 57
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 67
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 54
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 15
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 67
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 272
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 132
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 19
- num At Risk
- 67
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 204
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 97
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 67
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 87
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 67
- term
- Pyrexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 58
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 25
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 67
- term
- Nasopharyngitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 70
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 22
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 67
- term
- Contusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 155
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 74
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 67
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 61
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 20
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 67
- term
- Hyperglycaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 149
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 36
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 67
- term
- Hypokalaemia
Complete source fields
- description
- Following interim analysis of the study by the Independent Data Monitoring Committee in August 2010, the protocol was amended to provide for the unblinding of all study participants and the option for placebo participants to receive abiraterone acetate treatment; 67 placebo participants crossed over.
- event Groups
- description
- Abiraterone acetate plus prednisone/prednisolone administered as four 250 mg tablets of abiraterone acetate once daily plus 5 mg prednisone/5 mg prednisolone twice daily until disease progression.
- id
- EG000
- other Num Affected
- 766
- other Num At Risk
- 791
- serious Num Affected
- 365
- serious Num At Risk
- 791
- title
- Abiraterone Acetate
- description
- Placebo plus prednisone/prednisolone
- id
- EG001
- other Num Affected
- 381
- other Num At Risk
- 394
- serious Num Affected
- 175
- serious Num At Risk
- 394
- title
- Placebo
- description
- Placebo plus prednisone/prednisolone crossed over to abiraterone acetate plus prednisone/prednisolone
- id
- EG002
- other Num Affected
- 57
- other Num At Risk
- 67
- serious Num Affected
- 29
- serious Num At Risk
- 67
- title
- Placebo to Abiraterone Acetate
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 202
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 105
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 11
- num At Risk
- 67
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 236
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 124
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 67
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 166
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 57
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 67
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 54
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 15
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 67
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 272
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 132
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 19
- num At Risk
- 67
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 204
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 97
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 14
- num At Risk
- 67
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 87
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 67
- term
- Pyrexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 58
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 25
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 67
- term
- Nasopharyngitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 70
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 22
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 67
- term
- Contusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 155
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 74
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 67
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 61
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 20
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 67
- term
- Hyperglycaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 149
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 36
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 67
- term
- Hypokalaemia
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 26
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 15
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 67
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Coagulopathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Pancytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Bradycardia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Hypoacusis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Tinnitus
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Vertigo
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Hyperglycaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Blindness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA Version 11.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 791
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 394
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 67
- term
- Diplopia
- time Frame
- 5 years
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle